The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
NCT00937131
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Thrombotic Thrombocytopenic Purpura (TTP)
Interventions
DRUG:
Rituximab
Sponsor
University College, London